Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
03/2003
03/20/2003US20030055085 For therapy of stroke, head trauma, anoxic injury, ischemic injury, hypoglycemia, epilepsy, pain, migraine headaches, Parkinson's disease, senile dementia, Huntington's Chorea, anxiety, and Alzheimer's disease
03/20/2003US20030055068 Pyrazole compounds useful as protein kinase inhibitors
03/20/2003US20030055065 Administering tricyclic amide and urea compounds for inhibiting the abnormal growth of cells
03/20/2003US20030055057 1-alkyl-2-aryl-benzimidazole derivatives, their use for the production of pharmaceutial agents as well as pharmaceutical preparations that contain these derivatives
03/20/2003US20030055055 For inducing and maintaining anesthesia, sedation and muscle relaxation, as well as for combating febrile convulsions in children
03/20/2003US20030055054 CXCR3 antagonists
03/20/2003US20030055049 For therapy of abnormal cell growth, such as cancer, in mammals
03/20/2003US20030055044 Administering pyrazole derivative for inhibiting GSK-3 or Aurora activity in a patient
03/20/2003US20030052310 Perfluorinated amide salts and their uses as ionic conducting materials
03/20/2003CA2460347A1 3-glyoxlylamideindoles for treating cancer
03/20/2003CA2459515A1 Indole derivatives
03/20/2003CA2459464A1 Tetrahydropyran derivatives and their use as therapeutic agents
03/20/2003CA2459308A1 Cbi analogues of cc-1065 and the duocarmycins
03/19/2003EP1293503A1 Triazole derivatives
03/19/2003EP1293214A2 LTB4 antagonists and radiopharmaceuticals for imaging infection and inflammation
03/19/2003EP1292606A2 Positively-charged peptide nucleic acid analogs with improved properties
03/19/2003EP1292603A2 Methods and compositions for treating hepatitis c virus
03/19/2003EP1292594A1 Quinazoline derivatives for the treatment of tumours
03/19/2003EP1292592A1 Heterocyclic aminoalkyl pyridine derivatives as psychopharmaceuticals
03/19/2003EP1292591A2 Substituted bicyclic derivatives for the treatment of abnormal cell growth
03/19/2003EP1292579A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
03/19/2003EP1292575A2 1-aryl-4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents
03/19/2003EP1178984B1 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
03/19/2003EP1177192B1 Antifungal ethers
03/19/2003EP1157019B1 4-alkenyl (and alkynyl) oxindoles as inhibitors of cyclin-dependent kinases, in particular cdk2
03/19/2003EP0955293B1 Urea derivatives
03/19/2003EP0934312B1 1,4-disubstituted piperazines
03/19/2003CN1404480A Pyrimidine carboxamides useful as inhibitors of PDE4 isozymes
03/19/2003CN1404479A Novel 1,3-dihydro-2H-indol-2-one derivatives their preparing method and the pharmceutical composition containing the same
03/19/2003CN1404478A Pyridinylimidazoles
03/19/2003CN1404477A 哌嗪和哌啶衍生物 Piperazine and piperidine derivatives
03/19/2003CN1404476A Glycosidase inhibitors and preparation thereof
03/19/2003CN1404472A Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
03/19/2003CN1404470A 2-OXo-1-pyrrolidine derivatives, process for preparing them and their uses
03/19/2003CN1404469A 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
03/19/2003CN1403454A N-substituted nitrogen heterocyclic compound
03/19/2003CN1403453A Quinoline and quinazoline compound for treating benign prostatic hyperplasia specially
03/19/2003CN1403445A N-substituted nitrogen heterocyclic compound
03/18/2003US6535943 Information processing device enabling floating interrupt to be pending and a method executing an interrupt condition change instruction
03/18/2003US6534509 Derivatives are useful as anti-inflammatory agents. This invention is also directed to pharmacetutical compostions for inflammation
03/18/2003US6534496 Prophylactic and/or therapeutic drug for obesity and obesity associated diseasestor diabetes with a reduced risk for central side effects and high universality in usage. Another object of the a lipolytic agent, or a prophylactic and/or
03/18/2003US6534493 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
03/18/2003US6534445 Substituted pyridine herbicides
03/18/2003CA2236239C Quinoline and quinazoline compounds useful in therapy
03/18/2003CA2217351C Carbonyl-piperazinyl and piperidinyl compounds which inhibit farnesyl protein transferase
03/13/2003WO2003020717A1 Paroxetine isethionate salt, process of preparation and use in the treatment of depression
03/13/2003WO2003020703A1 Cyclic amine compound
03/13/2003WO2003020280A2 Compositions and use thereof in the treatment of cancer
03/13/2003WO2003004472A8 Arylamines for the treatment of conditions associated with gsk-3
03/13/2003WO2002096361A3 5-aralkylsulfonyl-3- (pyrrol-2-ylmethylidene)-2-indolinone derivatives as kinase inhibitors
03/13/2003WO2002096359A3 Piperazine pentanamide hiv protease inhibitors
03/13/2003WO2002096317A3 Method for treating glaucoma vi
03/13/2003WO2002076950A3 Imidiazole derivatives and their use as agonists selective at alpha 2b or 2b/2c adrenergic receptors
03/13/2003WO2002074726A3 Aniline derivatives useful as phosphodiesterase 4 inhibitors
03/13/2003WO2002036554A3 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis
03/13/2003WO2002013797A3 Therapeutic combination of a cetp inhibitor and atorvastatin
03/13/2003US20030050331 Cytotoxic agents
03/13/2003US20030050330 And inflammation-associated disorders, such as arthritis
03/13/2003US20030050320 A therapeutic agent for treating hepatitis C, based on polymerase inhibitory activity
03/13/2003US20030050309 A gelatinase inhibitor for modulating the activity of a dopamine, serotonin, or norepinephrine receptor or transporter
03/13/2003US20030050288 Substituted indoline derivative compounds which are antagonists of the progesterone receptor; oral contraception using multiphase progestotational agents, antiprogestins, indole or thiophene derivatives and placebo
03/13/2003US20030050229 Treatment with a 1' 2' and/or 3' nucleoside or a pharmaceutically acceptable salt or prodrug; nontoxic
03/13/2003CA2459584A1 Compositions and use thereof in the treatment of cancer
03/13/2003CA2456233A1 Paroxetine isethionate salt, process of preparation and use in the treatment of depression
03/12/2003EP1291346A1 Process for the preparation of trisubstituted imidazole compounds with multiple therapeutic properties
03/12/2003EP1291345A1 Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors
03/12/2003EP1289983A2 Heteroarylalkanoic acids as integrin receptor antagonists
03/12/2003EP1289982A1 Bioisosteric benzamide derivatives and their use as apob-100 secretion inhibitors
03/12/2003EP1289980A1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
03/12/2003EP1289969A1 Substituted n-benzoyl-n'-(tetrazolylphenyl)-ureas and their use as pest control agents
03/12/2003EP1289965A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
03/12/2003EP1289964A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
03/12/2003EP1289960A2 Cycloalkyl alkanoic acids as integrin receptor antagonists
03/12/2003EP1289957A1 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity
03/12/2003EP1289955A1 Piperidines for use as orexin receptor antagonists
03/12/2003EP1289954A1 Serine protease inhibitors
03/12/2003EP1289561A2 Ligand conjugates and methods for preparing same
03/12/2003EP1289525A2 Tricyclic pyrazole derivatives as protein kinase inhibitors
03/12/2003EP0923575B1 Cyclic ether compounds as sodium channel modulators
03/12/2003EP0670835B1 Process for preparing benzopyran compounds
03/12/2003CN1402712A Novel heterocyclic compounds and salts thereof and medicinal use of same
03/12/2003CN1402710A Antipicornaviral compound and compositions, their pharmaceutical uses, and material for their synthesis
03/12/2003CN1402708A Process for production of pyridine derivs.
03/11/2003US6531612 Nitrile derivatives that inhibit cathepsin K
03/11/2003US6531503 Benzofurane derivatives
03/11/2003US6531502 3-Methylidenyl-2-indolinone modulators of protein kinase
03/11/2003US6531497 Epothilone derivatives and their synthesis and use
03/11/2003US6531492 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
03/11/2003US6531473 Method of treatment using arylalkylpyridazinones
03/11/2003US6531139 Self-emulsifying formulation for lipophilic compounds
03/11/2003CA2262837C An asymmetric conjugate addition reaction
03/11/2003CA2254117C 2,4-diaminopyrimidine derivatives
03/10/2003CA2401358A1 Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors
03/06/2003WO2003018576A1 New piperidinyl-morpholinyl derivatives as modulators of chemokine receptor activity
03/06/2003WO2003018575A1 5-substituted-3(2h)-furanones useful for inhibition of farnesyl-protein transferase
03/06/2003WO2003018574A1 Rapamycin dialdehydes
03/06/2003WO2003018573A1 Rapamycin 29-enols
03/06/2003WO2003018568A2 Ascorbic acid derivatives, methods of synthesis and pharmaceutical use thereof
03/06/2003WO2003018555A1 Process for the preparation of indole derivatives
03/06/2003WO2003018538A1 Novel diarylalkene derivatives and novel diarylalkane derivatives
1 ... 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 ... 694